Raphael B Merriman

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94143 0538, USA
    Hepatology 44:874-80. 2006
  2. ncbi Nonalcoholic fatty liver disease and HIV infection
    Raphael B Merriman
    Division of Gastroenterology, Department of Medicine, 513 Parnassus Avenue, Room S 357, University of California, San Francisco, CA 94143 0538, USA
    Curr HIV/AIDS Rep 3:113-7. 2006
  3. ncbi Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging
    Antonio C A Westphalen
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 242:450-5. 2007
  4. ncbi Frequency and histopathologic basis of hepatic surface nodularity in patients with fulminant hepatic failure
    Jason A Poff
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Radiology 249:518-23. 2008
  5. ncbi Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade
    Susan M Noworolski
    Department of Radiology and Biomedical Imaging, Center for Molecular and Functional Imaging, University of California, San Francisco, 185 Berry St, Suite 350, Box 0946, San Francisco, CA 94107, USA
    Radiology 264:88-96. 2012
  6. ncbi Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques
    Mamak Eatesam
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143 0628, USA
    J Magn Reson Imaging 35:103-9. 2012
  7. ncbi Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers
    Manisha Bahl
    Department of Radiology, University of California, San Francisco, Box 0628, L 307, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 249:160-6. 2008
  8. ncbi Genetic influences in nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143, USA
    J Clin Gastroenterol 40:S30-3. 2006
  9. ncbi Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience
    Aliya Qayyum
    Department of Radiology, University of California San Francisco, CA 94143 0628, USA
    Radiology 237:507-11. 2005
  10. ncbi Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging
    Bachir Taouli
    Department of Radiology, University of California, San Francisco, CA, USA
    J Comput Assist Tomogr 29:425-9. 2005

Research Grants

  1. Genomic Determinants of Nonalcoholic Fatty Liver Disease
    Raphael Merriman; Fiscal Year: 2006

Detail Information

Publications20

  1. ncbi Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94143 0538, USA
    Hepatology 44:874-80. 2006
    ..In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease...
  2. ncbi Nonalcoholic fatty liver disease and HIV infection
    Raphael B Merriman
    Division of Gastroenterology, Department of Medicine, 513 Parnassus Avenue, Room S 357, University of California, San Francisco, CA 94143 0538, USA
    Curr HIV/AIDS Rep 3:113-7. 2006
    ..Histological-based, longitudinal studies are needed that address the interactions of NAFLD and HIV infection, the effects of antiretroviral therapy and hepatotropic virus coinfection, and inform better management strategies...
  3. ncbi Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging
    Antonio C A Westphalen
    Department of Radiology, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 242:450-5. 2007
    ..To retrospectively determine the effect of liver iron deposition on the evaluation of liver fat by using opposed-phase magnetic resonance (MR) imaging...
  4. ncbi Frequency and histopathologic basis of hepatic surface nodularity in patients with fulminant hepatic failure
    Jason A Poff
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    Radiology 249:518-23. 2008
    ..To determine the frequency and histopathologic basis of hepatic surface nodularity at imaging in patients with fulminant hepatic failure...
  5. ncbi Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade
    Susan M Noworolski
    Department of Radiology and Biomedical Imaging, Center for Molecular and Functional Imaging, University of California, San Francisco, 185 Berry St, Suite 350, Box 0946, San Francisco, CA 94107, USA
    Radiology 264:88-96. 2012
    ....
  6. ncbi Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques
    Mamak Eatesam
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143 0628, USA
    J Magn Reson Imaging 35:103-9. 2012
    ..To compare liver ADC obtained with breathhold and free-breathing diffusion weighted imaging (DWI) in healthy volunteers and patients with liver disease...
  7. ncbi Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers
    Manisha Bahl
    Department of Radiology, University of California, San Francisco, Box 0628, L 307, 505 Parnassus Ave, San Francisco, CA 94143 0628, USA
    Radiology 249:160-6. 2008
    ....
  8. ncbi Genetic influences in nonalcoholic fatty liver disease
    Raphael B Merriman
    Division of Gastroenterology, University of California, San Francisco, San Francisco, CA 94143, USA
    J Clin Gastroenterol 40:S30-3. 2006
    ..Identification of the genetic contribution to NAFLD will inform theories of disease pathogenesis and progression and ultimately improve management...
  9. ncbi Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience
    Aliya Qayyum
    Department of Radiology, University of California San Francisco, CA 94143 0628, USA
    Radiology 237:507-11. 2005
    ....
  10. ncbi Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging
    Bachir Taouli
    Department of Radiology, University of California, San Francisco, CA, USA
    J Comput Assist Tomogr 29:425-9. 2005
    ..To evaluate the growth rate of untreated hepatocellular carcinoma (HCC) by calculating tumor volume doubling time (TVDT) on serial computed tomography (CT) or magnetic resonance imaging (MRI) and to predict TVDT based on initial tumor size...
  11. ncbi Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies
    Abdurrahman Kadayifci
    Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA
    J Hepatol 49:595-9. 2008
    ....
  12. ncbi A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
    Guilherme M Campos
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143 0790, USA
    Hepatology 47:1916-23. 2008
    ....
  13. ncbi Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations
    Ivy R Aslan
    Department of Pediatrics, Division of Endocrinology, University of California San Francisco, San Francisco, CA 94143, USA
    Obes Surg 21:930-4. 2011
    ..Bariatric surgery is a successful treatment for severe obesity. The mechanisms of weight loss after bariatric surgery are not well understood...
  14. ncbi Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease
    Joanne B Krasnoff
    Exercise Physiology and Body Composition Laboratory, CTSI Clinical Research Center, University of California San Francisco, San Francisco, CA 94143 0126, USA
    Hepatology 47:1158-66. 2008
    ..048). Conclusion: Patients with NAFLD of differing histological severity have suboptimal HRF. Lifestyle interventions to improve HRF and PA may be beneficial in reducing the associated risk factors and preventing progression of NAFLD...
  15. ncbi Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol
    Oren K Fix
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Liver Transpl 13:875-85. 2007
    ..Liver biochemistries are not greatly changed. Survival seemed not to differ between treatment groups. A minority of patients treated with epoprostenol will improve sufficiently to undergo OLT...
  16. ncbi Medical treatment of non-alcoholic steatohepatitis
    Abdurrahman Kadayifci
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143 0538, USA
    Clin Liver Dis 11:119-40, ix. 2007
    ..The future will see the evaluation of novel agents and a comprehensive treatment strategy that addresses the risk factors for the metabolic syndrome. This article reviews the current status of medical management options for NASH...
  17. ncbi CT of benign hypervascular liver nodules in autoimmune hepatitis
    Aliya Qayyum
    Department of Radiology, University of California-San Francisco, 505 Parnassus Ave, San Francisco, CA 94143-0628, USA
    AJR Am J Roentgenol 183:1573-6. 2004
    ..This phenomenon is important to recognize because of the potential for confusion with hepatocellular carcinoma...
  18. ncbi Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers
    Bachir Taouli
    Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143, USA
    AJR Am J Roentgenol 183:677-80. 2004
    ..Our aim was to determine whether parallel imaging and diffusion tensor imaging affect the measurement of apparent diffusion coefficient (ADC) during diffusion-weighted MRI of the liver in healthy volunteers...
  19. ncbi Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease
    Abdurrahman Kadayifci
    Am J Gastroenterol 101:1396; author reply 1396-7. 2006
  20. ncbi Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists
    Matthew Ryan Riley
    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Lucile Salter Packard Children s Hospital, Stanford University, Palo Alto, California 94127, USA
    J Pediatr 147:839-42. 2005
    ....

Research Grants1

  1. Genomic Determinants of Nonalcoholic Fatty Liver Disease
    Raphael Merriman; Fiscal Year: 2006
    ..These projects will increase our understanding of NASH and with mentoring and coursework will foster the candidate's development as an independent researcher. ..